PIMA Point of Care CD4+ Cell Count Machines in Remote MNCH Settings: Lessons Learned from Seven Districts in Zimbabwe.
An evaluation was commissioned to generate evidence on the impact of PIMA point-of-care CD4+ count machines in maternal and new-born child health settings in Zimbabwe; document best practices, lessons learned, challenges, and recommendations related to scale up of this new technology. A mixed methodology approach that included 31 in-depth interviews with stakeholders involved in procurement, distribution, and use of the POC machines was employed. Additionally, data was also abstracted from 207 patient records from 35 sites with the PIMA POC CD4+ count machines and 10 other comparative sites without the machine. A clearer training strategy was found to be necessary. The average time taken to initiate clients on antiretroviral treatment (ART) was substantially less, 15 days (IQR-1-149) for sites with a PIMA POC machine as compared to 32.7 days (IQR-1-192) at sites with no PIMA POC machine. There was general satisfaction because of the presence of the PIMA POC CD4+ count machine at sites that also initiated ART.
National Microbiology Reference Laboratory, Harare, Zimbabwe.
Sekesai
S
Mtapuri-Zinyowera
National University of Science and Technology, Department of Applied Mathematics, Bulawayo, Zimbabwe.
Edward T
ET
Chiyaka
United Nations Children's Fund, Harare, Zimbabwe.
Wellington
W
Mushayi
United Nations Children's Fund, Harare, Zimbabwe.
Godfrey
G
Musuka
United Nations Children's Fund, Harare, Zimbabwe.
Florence
F
Naluyinda-Kitabire
Ministry of Health and Child Welfare, Harare, Zimbabwe.
Angella
A
Mushavi
University of Zimbabwe, Department of Community Medicine, Harare, Zimbabwe.
Vasco
V
Chikwasha
CD4+; MNCH settings; PIMA; lessons learnt; point of care